Skip to main content
. Author manuscript; available in PMC: 2011 Dec 6.
Published in final edited form as: Stroke. 2009 Apr 9;40(5):1926–1931. doi: 10.1161/STROKEAHA.108.540823

Table 2.

Studies of Concurrent Direct Cortical Stimulation and Physical Rehabilitation for Functional Recovery in Stroke

Study Phase Purpose Electrode Type Frequency Current
Duration
Behavioral Results Reorganization Results
Plautz et al (2003) Primate Feasibility and safety Subdural (circular 1.5 mm2) 50 Hz
50% MT
1 s
Improved distal forelimb function Expansion of distal forelimb representation in peri-infarct M1
Kleim et al (2003) Rodent Compare different polarities Subdural electrodes (0.4 mm2) 50 Hz
50% MT
1 s
Higher reach accuracy in monopolar cathodal group Increased functional peri-infarct cortex
Teskey et al (2003) Rodent Compare different frequencies Subdural (0.4×3 mm2) 0, 25, 50, 100,
250 Hz
50% MT
3 s
Frequency ≥50 Hz showed increased accuracy Frequency ≥50 Hz showed increased polysynaptic potentiation
Adkins-Muir and Jones (2003) Rodent Compare different frequencies Subdural (1×3 mm2) 0, 50, 250 Hz
50–70% MT
3 s
50-Hz group improved most in accuracy 50 Hz group— increased MAP-2 reactivity in the perilesional cortex
Adkins et al (2006) Rodent Compare polarities and try epidural method of electrode implantation Epidural (0.4×2 mm2) 0, 100 Hz
50% MT
3 s
Reaching performance better in stimulated groups Neuronal density increased in perilesional cortex in cathodal 100-Hz group
Adkins et al (2008) Animal Variation of Cortical stimulation effects based on impairment level Epidural monopolar 100 Hz
40–50% MT
Reaching improved in moderately impaired rats, not in severely impaired rats Moderately impaired rats showed increase in the efficacious synapses
Brown et al (2003) Human-single case Explore combined treatment in humans Epidural 50 Hz
4.5 mA
100 s
Improvement on pincer movement, UEFM, and SIS Not explored
Brown et al (2006) Human-Phase I (8 patients) Safety Epidural (3×3 array of 2-mm electrodes) 50 Hz
50% MT or 6.5 mA
3 s
Improvement on UEFM and SIS—2 patients withdrawn Not explored
Phase II (Huang et al, 2008; Levy et al, 2008) Human (24 patients) Efficacy and safety Epidural (2×3 array of 3-mm electrodes) 50 and 101 Hz
50% MT or 6.5 mA
3-s pulse trains
Combined group showed greater improvement on UEFM and AMAT Not explored
Phase III clinical trial Humans (146 patients) Effectiveness and safety Epidural (2×3 array of 3-mm electrodes) 50 Hz
50% MT or 6.5 mA
250-µs pulse
duration
Combined group not better than control group on UEFM and AMAT Not explored

SIS indicates Stroke Impact Scale; AMAT, Arm Motor Ability Test; MT, motor threshold; MAP, microtubule-associated protein.